To test this, immunocompetent wild-type (WT) mice were administered the pan-p38 inhibitor BIRB796 (p38α, β, γ, δ) (60) and weight loss and oral fungal burdens were assessed at days 1, 2 and 4 post-infection (p.i.). This evidence concerns the gene MAPK14 and infection.